Literature DB >> 25946983

Screening and referral for axial spondyloarthritis--need of the hour.

Abhijeet Danve1, Atul Deodhar.   

Abstract

Although axial spondyloarthritis (axSpA) is as prevalent as rheumatoid arthritis, it is commonly under recognized due to variety of reasons. AxSpA contributes to significant loss of function and disability among young adults. With the availability of newer assessment methods and effective therapeutic agents, early diagnosis and appropriate treatment are possible. As mechanical back pain is widely prevalent in general population, selection of patients with high likelihood of having axSpA and referral to rheumatologists is very important to allow prompt diagnosis and management of axSpA yet avoid improper utilization of resources. Various referral strategies have been developed for this purpose which have included patients with chronic back pain for >3 months with age of onset <45 years and one or more typical spondyloarthritis features with high sensitivity and specificity. Consistent application of both simple and complex strategies has demonstrated similar results in various clinical studies. About 35-45 % of patients referred to rheumatologists using these strategies were finally diagnosed to have axSpA. Potential referring providers include primary care physicians, physical therapists, orthopedic and spine surgeons, chiropractors, rehabilitation medicine physicians, ophthalmologists, gastroenterologists, and dermatologists. Increasing the awareness and education of the referring providers are two very important steps in the success of the referral strategy. With proper application of any strategy described below, a rheumatologist will need to see two to three patients with chronic back pain to identify one patient with axSpA.

Entities:  

Mesh:

Year:  2015        PMID: 25946983     DOI: 10.1007/s10067-015-2958-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  42 in total

Review 1.  The prevalence of low back pain: a systematic review of the literature from 1966 to 1998.

Authors:  B F Walker
Journal:  J Spinal Disord       Date:  2000-06

2.  Does male:female sex ratio in ankylosing spondylitis change with age?

Authors:  A T Masi; W R Wilkins
Journal:  J Rheumatol       Date:  1996-05       Impact factor: 4.666

Review 3.  Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort.

Authors:  Wonuk Lee; John D Reveille; John C Davis; Thomas J Learch; Michael M Ward; Michael H Weisman
Journal:  Ann Rheum Dis       Date:  2006-11-24       Impact factor: 19.103

4.  How to diagnose axial spondyloarthritis early.

Authors:  M Rudwaleit; D van der Heijde; M A Khan; J Braun; J Sieper
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

5.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; J Listing; N Akkoc; J Brandt; J Braun; C T Chou; E Collantes-Estevez; M Dougados; F Huang; J Gu; M A Khan; Y Kirazli; W P Maksymowych; H Mielants; I J Sørensen; S Ozgocmen; E Roussou; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2009-03-17       Impact factor: 19.103

6.  Performance of referral recommendations in patients with chronic back pain and suspected axial spondyloarthritis.

Authors:  Henning Christian Brandt; Inge Spiller; In-Ho Song; Janis L Vahldiek; Martin Rudwaleit; Joachim Sieper
Journal:  Ann Rheum Dis       Date:  2007-04-24       Impact factor: 19.103

7.  An epidemiological survey of low back pain and axial spondyloarthritis in a Chinese Han population.

Authors:  Z T Liao; Y F Pan; J L Huang; F Huang; W J Chi; K X Zhang; Z M Lin; Y Q Wu; W Z He; J Wu; X J Xie; J X Huang; Q J Wei; T W Li; Z Wu; B Y Yu; J R Gu
Journal:  Scand J Rheumatol       Date:  2009 Nov-Dec       Impact factor: 3.641

8.  The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis.

Authors:  Nigil Haroon; Robert D Inman; Thomas J Learch; Michael H Weisman; MinJae Lee; Mohammad H Rahbar; Michael M Ward; John D Reveille; Lianne S Gensler
Journal:  Arthritis Rheum       Date:  2013-10

9.  The prevalence of inflammatory back pain: population-based estimates from the US National Health and Nutrition Examination Survey, 2009-10.

Authors:  Michael H Weisman; James P Witter; John D Reveille
Journal:  Ann Rheum Dis       Date:  2012-07-11       Impact factor: 19.103

10.  Identifying patients with axial spondyloarthritis in primary care: how useful are items indicative of inflammatory back pain?

Authors:  A Braun; E Saracbasi; J Grifka; J Schnitker; J Braun
Journal:  Ann Rheum Dis       Date:  2011-08-05       Impact factor: 19.103

View more
  5 in total

1.  Editorial: Inflammatory Back Pain and Axial Spondyloarthritis: Lessons for Clinical Practice and Epidemiologic Research.

Authors:  Maureen Dubreuil; Joachim Sieper
Journal:  Arthritis Rheumatol       Date:  2018-05-07       Impact factor: 10.995

2.  Primary care physician perspectives on screening for axial spondyloarthritis: A qualitative study.

Authors:  Kate L Lapane; Divya Shridharmurthy; Sara Khan; Daniel Lindstrom; Ariel Beccia; Esther Yi; Jonathan Kay; Catherine Dube; Shao-Hsien Liu
Journal:  PLoS One       Date:  2021-05-24       Impact factor: 3.240

3.  Fever as an initial manifestation of spondyloarthritis: A retrospective study.

Authors:  Se Jin Byun; William Han Bae; Seung Min Jung; Sang-Won Lee; Yong-Beom Park; Jason Jungsik Song
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

Review 4.  Comparison of Clinical Manifestations in Rheumatoid Arthritis vs. Spondyloarthritis: A Systematic Literature Review.

Authors:  Philip J Mease; Mohit Kumar Bhutani; Steven Hass; Esther Yi; Peter Hur; Nina Kim
Journal:  Rheumatol Ther       Date:  2021-12-28

5.  Axial Spondyloarthritis in the Chiropractic Care Setting: A Systematic Literature Review.

Authors:  Atul Deodhar; Sonam Kiwalkar; Teja Mehendale; Shireesh Bhalerao
Journal:  J Clin Rheumatol       Date:  2022-03-01       Impact factor: 3.902

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.